STOCK TITAN

Aeternum Health flags going-concern doubt on $149K cash

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
10-Q

Rhea-AI Filing Summary

AETN reported no revenue from continuing operations for the nine months ended September 30, 2026, and a loss from continuing operations of $2,924,076. At September 30, cash was $149,107, working capital was in deficit by approximately $3.4 million, and operating activities used $1,677,548 in cash. Management said these conditions raise substantial doubt about the company’s ability to continue as a going concern for one year from issuance.

After its June 30 merger and divestiture of its legacy transportation-electrification business, AETN shifted to critical-mineral exploration and development. The Gyel tin, niobium and tantalum project in Nigeria includes a Phase 1 processing plant under construction; AETN has not established proven or probable mineral reserves. A September 21 agreement to acquire 100% of American Renaissance Minerals LLC, which holds the Nkamouna Nickel-Cobalt project in Cameroon, had not closed at September 30 and depends on closing conditions.

Disclosure controls and procedures were not effective as of September 30. Subsequent to quarter-end, AETN entered into SAFEs for aggregate purchase amounts of $1.91 million from eight investors, but had not received the funds by the date the financial statements were available to be issued. AETN effected a 1-for-20 reverse split of common stock on October 1.

0 points · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

1 major · 1 point

How the balance works

Positive

  • None.

Negative

  • Major pointGoing-concern warning: $149,107 cash, approximately $3.4 million deficit at September 30, 2026.
Revenue from continuing operations $0 Nine months ended September 30, 2026
Loss from continuing operations $2,924,076 Nine months ended September 30, 2026
Cash $149,107 As of September 30, 2026
Working capital deficit Approximately $3.4 million As of September 30, 2026
Net cash used in operating activities $1,677,548 Nine months ended September 30, 2026
Assets under construction $4,967,936 As of September 30, 2026; includes the Gyel Phase 1 processing plant and related project assets
SAFE aggregate purchase amounts $1.91 million Eight investors; entered into subsequent to September 30, 2026
Reverse stock split 1-for-20 Effective October 1, 2026
going concern financial
"raise substantial doubt about the Company’s ability to continue as a going concern"
Going concern is the accounting assumption that a company will keep operating and meeting its obligations for the foreseeable future. The phrase matters most when a company or its auditors disclose substantial doubt about it, a formal warning that the business may not have enough resources to continue without raising money, restructuring, or selling assets. That language in a filing or press release signals elevated financial risk.
proven or probable mineral reserves technical
"has not established proven or probable mineral reserves"
assets under construction financial
"Total assets under construction"
Simple Agreements for Future Equity financial
"entered into Simple Agreements for Future Equity (“SAFEs”)"
A simple agreement for future equity is a lightweight contract where an investor gives money now in exchange for the right to receive company shares at a later financing event, rather than buying shares immediately. Think of it as a voucher or IOU that converts into stock when the company raises a priced round; it matters to investors because it determines when they become owners, how much of the company they ultimately own, and how early risk and future dilution are shared.
post-money common stock share price cap financial
"post-money common stock share price cap of $1.60"
non-controlling interest financial
"presented as a non-controlling interest within equity"
Non-controlling interest represents the portion of ownership in a company held by investors who do not have a controlling stake, meaning they do not have enough voting power to make major decisions. It is similar to owning a minority share of a business partner’s company—while they benefit from profits, they cannot control how the company is run. This matters to investors because it shows how much of the company's value is owned by outside shareholders and affects overall financial reporting.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What conditions must AETN meet to close the ARM acquisition?

AETN's acquisition of 100% of American Renaissance Minerals LLC requires completion of ARM's financial statements, a $1,000,000 liability cap, an amended Gardiner Investments LLC note, and specified closing documents and a release. The agreement had not closed as of September 30, 2026. The note amendment must defer repayment to the earlier of the Initial Investment Decision Date and a Project Disposal; closing documents include consulting and investor-rights agreements with American Renaissance Resources LLC and a release from Andrew Horn. Either party may terminate if closing has not occurred by January 31, 2027.

How do AETN's post-quarter SAFEs convert?

AETN's eight post-quarter SAFEs automatically convert into common shares if an equity financing occurs before termination, using the greater of two share calculations. The calculations divide the purchase amount by either the lowest price per share paid in the financing or the price implied by the valuation cap. The SAFEs carry a $1.60 post-money common-stock share price cap per share, post-reverse split, and bear no interest or maturity date. On a liquidity event, the holder receives the greater of the purchase amount or the as-converted amount; on dissolution, the purchase amount is paid before any distribution to common stockholders.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false Q3 --12-31 0000764630 0000764630 2026-01-01 2026-09-30 0000764630 2026-11-10 0000764630 2026-09-30 0000764630 2025-12-31 0000764630 us-gaap:RelatedPartyMember 2026-09-30 0000764630 us-gaap:RelatedPartyMember 2025-12-31 0000764630 us-gaap:NonrelatedPartyMember 2026-09-30 0000764630 us-gaap:NonrelatedPartyMember 2025-12-31 0000764630 us-gaap:SeriesAPreferredStockMember 2026-09-30 0000764630 us-gaap:SeriesAPreferredStockMember 2025-12-31 0000764630 us-gaap:SeriesBPreferredStockMember 2026-09-30 0000764630 us-gaap:SeriesBPreferredStockMember 2025-12-31 0000764630 2026-07-01 2026-09-30 0000764630 2025-07-01 2025-09-30 0000764630 2025-01-01 2025-09-30 0000764630 us-gaap:CommonStockMember 2025-12-31 0000764630 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2025-12-31 0000764630 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0000764630 AETN:StockSubscribedMember 2025-12-31 0000764630 us-gaap:RetainedEarningsMember 2025-12-31 0000764630 us-gaap:TreasuryStockCommonMember 2025-12-31 0000764630 us-gaap:NoncontrollingInterestMember 2025-12-31 0000764630 us-gaap:CommonStockMember 2026-03-31 0000764630 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2026-03-31 0000764630 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0000764630 AETN:StockSubscribedMember 2026-03-31 0000764630 us-gaap:RetainedEarningsMember 2026-03-31 0000764630 us-gaap:TreasuryStockCommonMember 2026-03-31 0000764630 us-gaap:NoncontrollingInterestMember 2026-03-31 0000764630 2026-03-31 0000764630 us-gaap:CommonStockMember 2026-06-30 0000764630 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2026-06-30 0000764630 us-gaap:AdditionalPaidInCapitalMember 2026-06-30 0000764630 AETN:StockSubscribedMember 2026-06-30 0000764630 us-gaap:RetainedEarningsMember 2026-06-30 0000764630 us-gaap:TreasuryStockCommonMember 2026-06-30 0000764630 us-gaap:NoncontrollingInterestMember 2026-06-30 0000764630 2026-06-30 0000764630 us-gaap:CommonStockMember 2024-12-31 0000764630 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2024-12-31 0000764630 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0000764630 AETN:StockSubscribedMember 2024-12-31 0000764630 us-gaap:RetainedEarningsMember 2024-12-31 0000764630 us-gaap:TreasuryStockCommonMember 2024-12-31 0000764630 2024-12-31 0000764630 us-gaap:CommonStockMember 2025-03-31 0000764630 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2025-03-31 0000764630 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0000764630 AETN:StockSubscribedMember 2025-03-31 0000764630 us-gaap:RetainedEarningsMember 2025-03-31 0000764630 us-gaap:TreasuryStockCommonMember 2025-03-31 0000764630 2025-03-31 0000764630 us-gaap:CommonStockMember 2025-06-30 0000764630 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2025-06-30 0000764630 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0000764630 AETN:StockSubscribedMember 2025-06-30 0000764630 us-gaap:RetainedEarningsMember 2025-06-30 0000764630 us-gaap:TreasuryStockCommonMember 2025-06-30 0000764630 2025-06-30 0000764630 us-gaap:CommonStockMember 2026-01-01 2026-03-31 0000764630 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2026-01-01 2026-03-31 0000764630 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-03-31 0000764630 AETN:StockSubscribedMember 2026-01-01 2026-03-31 0000764630 us-gaap:RetainedEarningsMember 2026-01-01 2026-03-31 0000764630 us-gaap:TreasuryStockCommonMember 2026-01-01 2026-03-31 0000764630 us-gaap:NoncontrollingInterestMember 2026-01-01 2026-03-31 0000764630 2026-01-01 2026-03-31 0000764630 us-gaap:CommonStockMember 2026-04-01 2026-06-30 0000764630 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2026-04-01 2026-06-30 0000764630 us-gaap:AdditionalPaidInCapitalMember 2026-04-01 2026-06-30 0000764630 AETN:StockSubscribedMember 2026-04-01 2026-06-30 0000764630 us-gaap:RetainedEarningsMember 2026-04-01 2026-06-30 0000764630 us-gaap:TreasuryStockCommonMember 2026-04-01 2026-06-30 0000764630 us-gaap:NoncontrollingInterestMember 2026-04-01 2026-06-30 0000764630 2026-04-01 2026-06-30 0000764630 us-gaap:CommonStockMember 2026-07-01 2026-09-30 0000764630 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2026-07-01 2026-09-30 0000764630 us-gaap:AdditionalPaidInCapitalMember 2026-07-01 2026-09-30 0000764630 AETN:StockSubscribedMember 2026-07-01 2026-09-30 0000764630 us-gaap:RetainedEarningsMember 2026-07-01 2026-09-30 0000764630 us-gaap:TreasuryStockCommonMember 2026-07-01 2026-09-30 0000764630 us-gaap:NoncontrollingInterestMember 2026-07-01 2026-09-30 0000764630 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0000764630 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2025-01-01 2025-03-31 0000764630 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0000764630 AETN:StockSubscribedMember 2025-01-01 2025-03-31 0000764630 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0000764630 us-gaap:TreasuryStockCommonMember 2025-01-01 2025-03-31 0000764630 2025-01-01 2025-03-31 0000764630 us-gaap:CommonStockMember 2025-04-01 2025-06-30 0000764630 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2025-04-01 2025-06-30 0000764630 us-gaap:AdditionalPaidInCapitalMember 2025-04-01 2025-06-30 0000764630 AETN:StockSubscribedMember 2025-04-01 2025-06-30 0000764630 us-gaap:RetainedEarningsMember 2025-04-01 2025-06-30 0000764630 us-gaap:TreasuryStockCommonMember 2025-04-01 2025-06-30 0000764630 2025-04-01 2025-06-30 0000764630 us-gaap:CommonStockMember 2025-07-01 2025-09-30 0000764630 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2025-07-01 2025-09-30 0000764630 us-gaap:AdditionalPaidInCapitalMember 2025-07-01 2025-09-30 0000764630 AETN:StockSubscribedMember 2025-07-01 2025-09-30 0000764630 us-gaap:RetainedEarningsMember 2025-07-01 2025-09-30 0000764630 us-gaap:TreasuryStockCommonMember 2025-07-01 2025-09-30 0000764630 us-gaap:CommonStockMember 2026-09-30 0000764630 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2026-09-30 0000764630 us-gaap:AdditionalPaidInCapitalMember 2026-09-30 0000764630 AETN:StockSubscribedMember 2026-09-30 0000764630 us-gaap:RetainedEarningsMember 2026-09-30 0000764630 us-gaap:TreasuryStockCommonMember 2026-09-30 0000764630 us-gaap:NoncontrollingInterestMember 2026-09-30 0000764630 us-gaap:CommonStockMember 2025-09-30 0000764630 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2025-09-30 0000764630 us-gaap:AdditionalPaidInCapitalMember 2025-09-30 0000764630 AETN:StockSubscribedMember 2025-09-30 0000764630 us-gaap:RetainedEarningsMember 2025-09-30 0000764630 us-gaap:TreasuryStockCommonMember 2025-09-30 0000764630 2025-09-30 0000764630 us-gaap:NonrelatedPartyMember 2026-01-01 2026-09-30 0000764630 us-gaap:NonrelatedPartyMember 2025-01-01 2025-09-30 0000764630 us-gaap:RelatedPartyMember 2026-01-01 2026-09-30 0000764630 us-gaap:RelatedPartyMember 2025-01-01 2025-09-30 0000764630 AETN:PaulMannMember 2026-02-17 0000764630 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2026-02-17 2026-02-17 0000764630 2026-02-17 2026-02-17 0000764630 us-gaap:CommonStockMember 2026-02-17 2026-02-17 0000764630 AETN:AeternumHealthIncMember 2026-03-02 0000764630 AETN:AeternumHealthIncMember 2026-03-03 0000764630 us-gaap:CommonStockMember 2026-05-28 2026-05-28 0000764630 AETN:AeternumNGMember 2026-07-23 0000764630 AETN:AeternumNGMember AETN:TwoShareHoldersMember 2026-07-23 0000764630 AETN:AeternumNGMember 2026-08-19 0000764630 AETN:AeternumNGMember us-gaap:SubsequentEventMember 2026-10-01 2026-10-01 0000764630 AETN:AeternumNGMember 2026-09-30 0000764630 AETN:AeternumNGMember 2026-08-01 2026-08-01 0000764630 AETN:ThirdPartyMember 2026-09-30 0000764630 AETN:ThirdPartyMember 2025-12-31 0000764630 AETN:AeternumNGMember 2026-01-01 2026-06-30 0000764630 AETN:AeternumNGMember 2026-01-01 2026-09-30 0000764630 AETN:AeternumNGMember 2025-07-01 2025-09-30 0000764630 AETN:AeternumNGMember 2025-01-01 2025-09-30 0000764630 AETN:JeffKimMember 2026-09-30 0000764630 AETN:JeffKimMember 2026-01-01 2026-09-30 0000764630 AETN:JeffKimMember 2025-01-01 2025-12-31 0000764630 AETN:KimMember 2026-02-16 2026-02-17 0000764630 AETN:KimMember 2026-03-16 2026-03-16 0000764630 AETN:KimMember 2026-05-02 2026-05-02 0000764630 AETN:PaulMannMember 2026-01-01 2026-09-30 0000764630 AETN:PaulMannMember 2026-01-01 2026-06-30 0000764630 AETN:PaulMannMember 2026-07-01 2026-09-30 0000764630 AETN:MrMannMember 2026-08-26 0000764630 AETN:MrMannMember 2026-08-26 2026-08-26 0000764630 AETN:MrMannMember 2026-09-30 0000764630 AETN:MrMannMember 2025-10-28 2025-10-28 0000764630 us-gaap:CommonStockMember AETN:MrMannMember 2026-07-22 2026-07-22 0000764630 us-gaap:CommonStockMember AETN:MrMannMember 2026-08-26 2026-08-26 0000764630 AETN:MrMannMember AETN:SidleyLLCMember 2026-08-26 2026-08-26 0000764630 AETN:MrMannMember AETN:SidleyLLCMember 2026-07-01 2026-07-01 0000764630 AETN:SidleyLLCMember AETN:MrMannMember 2026-09-30 0000764630 AETN:GlobalCriticalMineralsLLCMember 2026-09-07 0000764630 AETN:GlobalCriticalMineralsLLCMember 2026-09-16 0000764630 AETN:GlobalCriticalMineralsLLCMember 2026-09-30 0000764630 AETN:MrKimMember 2026-07-28 2026-07-28 0000764630 AETN:ManasluLLCMember 2026-08-26 2026-08-26 0000764630 AETN:MrMannMember 2026-01-01 2026-09-30 0000764630 AETN:MrMannMember AETN:DecemberThirtyOneTwoThousandTwentyFiveMember 2026-09-30 0000764630 AETN:MrMannMember AETN:JanuaryToJuneTwentyTwentySixMember 2026-09-30 0000764630 AETN:MrMannMember AETN:JulyToSeptemberTwentyTwentySixMember 2026-09-30 0000764630 AETN:MrMannMember AETN:AugustTwentyTwentySixMember 2026-09-30 0000764630 AETN:MrMannMember 2026-09-30 0000764630 AETN:ManasluLLCMember 2026-08-07 0000764630 2026-08-07 0000764630 us-gaap:SeriesBPreferredStockMember 2026-08-07 0000764630 us-gaap:CommonStockMember 2026-08-26 2026-08-26 0000764630 AETN:MembershipInterestPurchaseAgreementMember 2026-09-21 2026-09-21 0000764630 us-gaap:CommonStockMember srt:MinimumMember 2026-01-01 2026-09-30 0000764630 us-gaap:CommonStockMember srt:MaximumMember 2026-01-01 2026-09-30 0000764630 AETN:AmericanRenaissanceMineralsLLCMember 2026-09-30 0000764630 AETN:GardinerInvestmentsLLCMember 2026-09-30 0000764630 us-gaap:CommonStockMember AETN:OpConnectIncMember 2026-02-17 2026-02-17 0000764630 2026-02-17 0000764630 us-gaap:CommonStockMember AETN:EropEnterprisesLlcMember 2026-02-17 2026-02-17 0000764630 us-gaap:CommonStockMember AETN:EropEnterprisesLlcMember 2026-02-16 2026-02-16 0000764630 AETN:EropEnterprisesLlcMember us-gaap:CommonStockMember 2026-03-16 2026-03-16 0000764630 us-gaap:CommonStockMember AETN:ThirdPartyMember 2026-02-17 2026-02-17 0000764630 AETN:ThirdPartyMember us-gaap:CommonStockMember 2026-03-16 2026-03-16 0000764630 us-gaap:CommonStockMember AETN:ThirdPartyMember 2026-04-24 2026-04-24 0000764630 us-gaap:CommonStockMember 2026-05-14 2026-05-14 0000764630 2026-05-14 0000764630 us-gaap:CommonStockMember AETN:PaulMannMember 2026-07-22 2026-07-22 0000764630 us-gaap:CommonStockMember 2026-07-28 2026-07-28 0000764630 us-gaap:CommonStockMember AETN:MrKimMember 2026-07-28 2026-07-28 0000764630 us-gaap:CommonStockMember AETN:ManasluLLCMember 2026-08-26 2026-08-26 0000764630 us-gaap:CommonStockMember AETN:MrKimMember 2026-08-26 2026-08-26 0000764630 us-gaap:CommonStockMember AETN:MrMannMember 2026-08-26 0000764630 srt:MaximumMember 2026-09-30 0000764630 AETN:PCSManagementLLCMember 2026-09-30 0000764630 AETN:PaulSohnMember 2026-09-30 0000764630 us-gaap:SubsequentEventMember 2026-10-01 2026-10-01 0000764630 2026-08-19 0000764630 us-gaap:SeriesAPreferredStockMember 2026-01-01 2026-09-30 0000764630 srt:MinimumMember us-gaap:SeriesBPreferredStockMember 2026-09-30 0000764630 srt:MaximumMember us-gaap:SeriesBPreferredStockMember 2026-09-30 0000764630 us-gaap:MiningPropertiesAndMineralRightsMember 2026-09-30 0000764630 AETN:LandAndSurfacesRightsMember 2026-09-30 0000764630 AETN:MineralRightsAndLandMember 2026-09-30 0000764630 us-gaap:VehiclesMember 2026-09-30 0000764630 AETN:EarthworksAndCivilsMember 2026-09-30 0000764630 us-gaap:PropertyPlantAndEquipmentMember 2026-09-30 0000764630 AETN:MiningDredgingAndPumpingEquipmentMember 2026-09-30 0000764630 AETN:PowerElectricalAndInstrumentationMember 2026-09-30 0000764630 AETN:SiteInfrastructureAndServicesMember 2026-09-30 0000764630 AETN:BuildingsAndFurnitureMember 2026-09-30 0000764630 AETN:EngineeringProjectManagementAndStudiesMember 2026-09-30 0000764630 AETN:TransportFreightAndImportDutiesMember 2026-09-30 0000764630 us-gaap:AssetUnderConstructionMember 2026-09-30 0000764630 us-gaap:MiningPropertiesAndMineralRightsMember 2026-07-01 2026-09-30 0000764630 us-gaap:PropertyPlantAndEquipmentMember 2026-07-01 2026-09-30 0000764630 us-gaap:SubsequentEventMember AETN:StoneXFinancialIncMember 2026-10-06 0000764630 AETN:SimpleAgreementsFutureEquityMember us-gaap:SubsequentEventMember 2026-10-01 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington D.C. 20549

 

FORM 10-Q

 

(Mark One)

 

☒ QUARTERLY REPORT UNDER SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2026

 

☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT

 

For the transition period from ___to___

 

Commission File Number 001-15913

 

AETERNUM RESOURCES, INC.

(Exact Name of Registrant as Specified in Its Charter)

 

Delaware   06-1120072
(State or other jurisdiction of   (I.R.S. Employer
incorporation or organization)   Identification No.)

 

5289 NE Elam Young Pkwy, Suite 180, Hillsboro, OR 97124

(Address of Principal Executive Offices)

 

(503) 892-7345

(Registrant’s Telephone Number, Including Area Code)

Aeternum Health, Inc.

 

(Former Name, Former Address and Former Fiscal Year, if Changed Since Last Report)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock   AETN   OTC PINK

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (Section 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐   Accelerated filer ☐
Non-accelerated filer ☒   Smaller reporting company ☒
Emerging Growth Company ☐    

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock as of the latest practicable date. As of November 10, 2026, there were 13,105,980 shares of Common Stock, $0.01 par value per share, outstanding.

 

 

 

 

 

 

AETERNUM RESOURCES, INC.

 

Form 10-Q

For the Quarterly Period Ended September 30, 2026

 

INDEX

 

PART I Financial Information  
Item 1. Financial Statements (unaudited) 3
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 19
Item 3. Quantitative and Qualitative Disclosures about Market Risk 21
Item 4. Controls and Procedures 21
     
PART II Other Information  
Item 1. Legal Proceedings 22
Item 1A. Risk Factors 22
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 22
Item 3. Defaults Upon Senior Securities 22
Item 4. Mine Safety Disclosures 22
Item 5. Other Information 22
Item 6. Exhibits 22
Signatures 23

 

2

 

 

PART I

FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS.

 

Condensed Consolidated Balance Sheets as of September 30, 2026 (unaudited) and December 31, 2025 4
   
Condensed Consolidated Statements of Operations for the Three and Nine Months Ended September 30, 2026 and 2025 (unaudited) 5
   
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Deficit) for the Three and Nine Months Ended September 30, 2026 and 2025 (unaudited) 6
   
Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2026 and 2025 (unaudited) 7
   
Notes to the Financial Statements (unaudited) 8

 

3

 

 

AETERNUM RESOURCES, INC.

(formerly AETERNUM HEALTH, INC. and SHOREPOWER TECHNOLOGIES INC.)

 

CONDENSED CONSOLIDATED BALANCE SHEETS

 

   September 30, 2026   December 31, 2025 
   (Unaudited)   (Audited) 
ASSETS          
Current Assets:          
Cash  $149,107   $15,374 
Deposits, prepaids and other current assets   1,354    — 
Accounts receivable   —    984 
Inventory   —    37,199 
Total Current Assets   150,461    53,557 
           
Non-Current Assets:          
Property, plant and equipment, including assets under construction   5,048,940    — 
Mineral rights and land   1,992,557    — 
Other asset   —    1,000 
Total non-current assets   7,041,497    1,000 
           
Total Assets  $7,191,958   $54,557 
           
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)          
Current Liabilities:          
Accounts payable and accrued expenses  $1,580,002   $125,049 
Accounts payable – related party   —    48,864 
Accrued officer compensation – related party   —    506,668 
Accrued consulting fees – related party   90,000    — 
Accrued interest – related party   —    216,014 
Loan payable – related party (Sidley LLC)   853,509    — 
Loan payable – related party (Global Critical Minerals LLC)   977,522    — 
Notes payable – related party   —    125,775 
Note payable   —    111,395 
Total Current Liabilities   3,501,033    1,133,765 
           
Notes payable, net of current portion – related party   2,580,348    919,678 
           
Total Liabilities   6,081,381    2,053,443 
           
Commitments and contingencies   —    — 
           
Stockholders’ Equity (Deficit):          
Preferred stock, $0.01 par value, 10,000,000 shares authorized;   —    — 
Series A preferred stock, $0.01 par value, 1,105,644 shares designated; no shares issued and outstanding   —    — 
Series B preferred stock, $0.01 par value, 2,000,000 shares designated; 2,000,000 issued and outstanding   20,000    20,000 
Common stock, $0.01 par value, 500,000,000 shares authorized; 13,105,260 and 2,459,510 shares issued at September 30, 2026 and December 31, 2025, respectively   131,053    24,595 
Additional paid-in capital   3,585,781    1,277,114 
Common stock subscriptions received – shares to be issued   1,775,000    — 
Treasury stock, at cost; 1,999 and 1,999 shares of common stock, respectively   (42,454)   (42,454)
Accumulated deficit   (4,238,001)   (3,278,141)
Total stockholders’ equity (deficit)   1,231,379    (1,998,886)
Non-controlling interest   (120,802)   — 
Total equity (deficit)   1,110,577    (1,998,886)
           
Total Liabilities and Stockholders’ Equity (Deficit)  $7,191,958   $54,557 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

4

 

 

AETERNUM RESOURCES, INC.

(formerly AETERNUM HEALTH, INC. and SHOREPOWER TECHNOLOGIES INC.)

 

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

 

   2026   2025   2026   2025 
   For the Three Months Ended September 30,   For the Nine Months Ended September 30, 
   2026   2025   2026   2025 
Operating Expenses:                    
Exploration expenditures  $431,582   $—   $521,804   $— 
Project start-up and pre-production costs   402,678    —    405,874    — 
Community and social investment   36,630    —    36,630    — 
Staff and contractor costs   222,577    —    267,456    — 
Travel and events   232,784    —    232,784    — 
Professional fees   238,188    —    393,578    — 
Investor relations and listing   22,829    —    23,422    — 
Insurance   168,044    —    168,044    — 
IT and systems   26,637    —    32,451    — 
Other administrative expenses   25,834    —    26,619    — 
Share-based compensation – related party   800,000    —    800,000    — 
Total operating expenses   2,607,783    —    2,908,662    — 
                     
Loss from Operations   (2,607,783)   —    (2,908,662)   — 
                     
Other Expense:                    
Foreign exchange loss   (15,414)   —    (15,414)   — 
Total other expense   (15,414)   —    (15,414)   — 
                     
Loss before income tax   (2,623,197)   —    (2,924,076)   — 
Income tax expense   —    —    —    — 
Net loss from continuing operations   (2,623,197)   —    (2,924,076)   — 
                     
Discontinued operations:                    
Loss from operations of discontinued business   —    (137,860)   (153,553)   (237,824)
Gain on spin-out of discontinued business   —    —    2,037,315    — 
Income (loss) from discontinued business   —    (137,860)   1,883,762    (237,824)
                     
Net Loss  $(2,623,197)  $(137,860)  $(1,040,314)  $(237,824)
Less: net loss attributable to non-controlling interest   (120,802)   —    (120,802)   — 
Net loss attributable to Aeternum Resources, Inc.  $(2,502,395)  $(137,860)  $(919,512)  $(237,824)
                     
Net loss per share from continuing operations, basic and diluted  $(0.33)  $—   $(0.70)  $— 
Net income (loss) loss per share from discontinued operations, basic and diluted  $—   $(0.06)  $0.45   $(0.10)
Net loss per share, basic and diluted  $(0.33)  $(0.06)  $(0.22)  $(0.10)
                     
Weighted Average Number of Common Shares: Basic and Diluted   7,564,048    2,459,510    4,186,845    2,449,997 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

5

 

 

AETERNUM RESOURCES, INC.

(formerly AETERNUM HEALTH, INC. and SHOREPOWER TECHNOLOGIES INC.)

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT)

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2026 AND 2025

(Unaudited)

 

   Shares   Amount   Shares   Amount   Capital   Subscribed   Deficit   Shares   Amount   Interest   (Deficit) 
   Common Stock   Series B Preferred Stock   Additional Paid-in   Stock   Accumulated   Treasury Stock   Non-controlling   Total Equity 
   Shares   Amount   Shares   Amount   Capital   Subscribed   Deficit   Shares   Amount   Interest   (Deficit) 
December 31, 2025   2,459,510   $24,595    2,000,000   $20,000   $1,277,114   $—   $(3,278,141)   1,999   $(42,454)  $—   $(1,998,886)
Common stock issued for intangible asset   50,000    500    —    —    14,500    —    —    —    —    —    15,000 
Common stock issued for services   5,000    50    —    —    1,450    —    —    —    —    —    1,500 
Common stock issued for cash   65,000    650    —    —    46,850    —    —    —    —    —    47,500 
Common stock issued for cash – related party   30,000    300    —    —    12,200    —    —    —    —    —    12,500 
Net loss   —    —    —    —    —    —    (139,655)   —    —    —    (139,655)
March 31, 2026   2,609,510    26,095    2,000,000    20,000    1,352,114    —    (3,417,796)   1,999    (42,454)   —    (2,062,041)
Common stock issued for services   1,250    13    —    —    2,612    —    —    —    —    —    2,625 
Common stock issued for cash   25,000    250    —    —    29,750    —    —    —    —    —    30,000 
Common stock issued for cash – related party   5,000    50    —    —    5,950    —    —    —    —    —    6,000 
Accumulated deficit assumed in merger   —    —    —    —    —    —    (40,348)   —    —    —    (40,348)
Net income   —    —    —    —    —    —    1,722,538    —    —    —    1,722,538 
June 30, 2026   2,640,760    26,408    2,000,000    20,000    1,390,426    —    (1,735,606)   1,999    (42,454)   —    (341,226)
Common stock issued pursuant to merger agreement   2,450,000    24,500    —    —    (24,500)   —    —    —    —    —    — 
Common stock issued for finder’s fees   96,000    960    —    —    (960)   —    —    —    —    —    — 
Common stock issued – Manaslu LLC   2,500,000    25,000    —    —    (25,000)   —    —    —    —    —    — 
Common stock issued in exchange for related party notes payable   3,750,000    37,500    —    —    1,462,500    —    —    —    —    —    1,500,000 
Stock-based compensation – related party   2,000,000    20,000    —    —    780,000    —    —    —    —    —    800,000 
Common stock cancelled and returned by former officer   (331,500)   (3,315)   —    —    3,315    —    —    —    —    —    — 
Common stock subscriptions received – shares to be issued   —    —    —    —    —    1,775,000    —    —    —    —    1,775,000 
Net loss   —    —    —    —    —    —    (2,502,395)   —    —    (120,802)   (2,623,197)
September 30, 2026   13,105,260   $131,053    2,000,000   $20,000   $3,585,781   $1,775,000   $(4,238,001)   1,999   $(42,454)  $(120,802)  $1,110,577 

 

   Shares   Amount   Shares   Amount   Capital   Subscribed   Deficit   Shares   Amount   (Deficit) 
   Common Stock   Series B Preferred Stock   Additional Paid-in   Stock   Accumulated   Treasury Stock   Total Equity 
   Shares   Amount   Shares   Amount   Capital   Subscribed   Deficit   Shares   Amount   (Deficit) 
December 31, 2024   2,423,934   $24,239    2,000,000   $20,000   $1,263,240   $—   $(2,941,047)   1,999   $(42,454)  $(1,676,022)
Common stock issued for services   35,576    356    —    —    13,874    —    —    —    —    14,230 
Net income from discontinued operations   —    —    —    —    —    —    5,891    —    —    5,891 
March 31, 2025   2,459,510    24,595    2,000,000    20,000    1,277,114    —    (2,935,156)   1,999    (42,454)   (1,655,901)
Net loss from discontinued operations   —    —    —    —    —    —    (105,855)   —    —    (105,855)
June 30, 2025   2,459,510    24,595    2,000,000    20,000    1,277,114    —    (3,041,011)   1,999    (42,454)   (1,761,756)
Net loss from discontinued operations   —    —    —    —    —    —    (137,860)   —    —    (137,860)
September 30, 2025   2,459,510   $24,595    2,000,000   $20,000   $1,277,114   $—   $(3,178,871)   1,999   $(42,454)  $(1,899,616)

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

6

 

 

AETERNUM RESOURCES, INC.

(formerly AETERNUM HEALTH, INC. and SHOREPOWER TECHNOLOGIES INC.)

 

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

   2026   2025 
   For the Nine Months Ended September 30, 
   2026   2025 
Cash Flows from Operating Activities:          
Net loss  $(1,040,314)  $(237,824)
Adjustments to reconcile net loss to net cash used in operating activities:          
Loss from discontinued operations   153,553    — 
Gain on disposal of Shorepower Technologies   (2,037,315)   — 
Stock compensation   804,125    — 
Expenses paid directly by related party on behalf of the Company   180,609    — 
Changes in operating assets and liabilities:          
Deposits, prepaids and other current assets   (1,354)   — 
Accounts payable, accrued expenses and other payables   318,646    — 
Accrued consulting – related party   60,000    — 
Net cash provided by (used in) operating activities of discontinued operations   (115,498)   273,373 
Net cash provided by (used in) operating activities   (1,677,548)   35,549 
           
Cash Flows from Investing Activities:          
Purchase of property, plant and equipment and mineral rights   (4,707,241)   — 
Net cash used in investing activities   (4,707,241)   — 
           
Cash Flows from Financing Activities:          
Loans from related parties   4,070,000    5,000 
Loan from related party – Global Critical Minerals LLC   977,522    — 
Repayment of related party loans   (400,000)   (5,000)
Proceeds from common stock subscriptions   1,775,000    — 
Proceeds from sale of common stock   77,500    — 
Proceeds from sale of common stock – related party   18,500    — 
Net cash provided by financing activities   6,518,522    — 
           
Net change in cash   133,733    35,549 
Cash, beginning of period   15,374    18,332 
Cash, end of period  $149,107   $53,881 
           
Cash paid for:          
Interest paid  $—   $— 
Income tax paid  $—   $— 
           
Supplemental disclosures of non-cash investing and financing activities:          
Property, plant and equipment and mineral rights paid directly by related party  $1,072,900   $— 
Property, plant and equipment included in accounts payable and other payables  $1,261,356   $— 
Common stock issued for intangible asset  $15,000   $— 
Common stock issued in exchange for related party notes payable  $1,500,000   $— 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

7

 

 

AETERNUM RESOURCES, INC.

(formerly AETERNUM HEALTH, INC. and SHOREPOWER TECHNOLOGIES INC.)

 

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

 

NOTE 1 – ORGANIZATION AND DESCRIPTION OF BUSINESS

 

Aeternum Resources, Inc. (formerly Aeternum Health, Inc.) (“AETN,” “Aeternum” or “the Company”), formerly known as Shorepower Technologies Inc. (“Shorepower”), is a Delaware corporation incorporated on May 29, 1984.

 

On February 17, 2026, the Company entered into a merger agreement with Aeternum Health LLC, pursuant to which Aeternum Health LLC was merged into Shorepower, with Aeternum Health LLC as the surviving entity. Aeternum Health LLC is a Delaware limited liability company formed on October 16, 2025. The Company is headquartered in Hillsboro, OR. Upon closing, Shorepower’s CEO and sole director, Jeff Kim, resigned all positions. The Company has divested its existing transportation electrification business and has shifted its focus to mineral opportunities

As consideration for the merger, the Company is obligated to issue shares representing 51% ownership and 2,000,000 shares of Series B preferred stock (with super voting rights) to Paul Mann. Aeternum Health will contribute assets of at least $1.5 million in value including intellectual property and data related to critical mineral mining and a peptide-based longevity treatment, and a related commercialization business. In connection with the transaction, Jeff Kim has agreed to cancel up to 650,000 shares of common stock in stages.

 

On March 3, 2026, FINRA announced in the Daily List the Company’s change of its name to Aeternum Health, Inc., and its trading symbol to AETN. In anticipation of completing the merger, the Company has increased its authorized shares from 100 million to 250 million effective April 3, 2026. The merger became effective on June 30, 2026.

 

On June 10, 2026, the Company formed Aeternum Cayman Islands Ltd, incorporated in the Cayman Islands as an exempted company with limited liability.

 

On May 28, 2026, the Company formed Aeternum SA (Pty) Ltd, incorporated in South Africa as a private company. The documents also show Aeternum Cayman Islands Ltd as the registered shareholder of 100 ordinary shares.

 

On July 23, 2026, the Company formed Aeternum Resources NG Limited (“Aeternum NG”), a Nigerian private company limited by shares. Aeternum Cayman Islands Ltd owns 90% of Aeternum NG, and two local shareholders each own 5%. Aeternum NG holds the Gyel tin, niobium and tantalum project on the Jos Plateau in Nigeria.

 

Following the merger, the Company’s business is the exploration and development of critical minerals. Its principal project is the Gyel project, where the Company is constructing a Phase 1 processing plant. The Company has not established proven or probable mineral reserves and is an exploration stage issuer under subpart 1300 of Regulation S-K. Aeternum SA (Pty) Ltd provides group office and technical services.

 

The Company’ name change to Aeternum Resources, Inc. was filed with the Delaware Secretary of State on August 7, 2026, and was changed for trading purposes on the OTC:Pink market following FINRA completing its review of this corporate action on October 2, 2026. Effective August 19, 2026, the Company increased its authorized common stock to 500,000,000 shares. Effective October 1, 2026, the Company effected a 1-for-20 reverse stock split of its common stock. All share and per-share amounts in these financial statements have been retroactively adjusted for the reverse stock split (Note 12).

 

8

 

 

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Unaudited Interim Financial Information

 

The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules of the Securities and Exchange Commission (“SEC”), and should be read in conjunction with the audited financial statements and notes thereto contained in the Company’s latest Annual Report on Form 10-K filed with the SEC. In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of the results of operations for the interim periods presented have been reflected herein. The results of operations for interim periods are not necessarily indicative of operations for the full year. Notes to the financial statements which would substantially duplicate the disclosures contained in the audited financial statements for the most recent fiscal year, as reported in the Form 10-K for the fiscal year ended December 31, 2025, have been omitted. The condensed unaudited financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America (“US GAAP”).

 

Principles of Consolidation

 

The condensed consolidated financial statements include the accounts of the Company and its subsidiaries:

 

Name   Background   Ownership
Aeternum Resources Inc.   A US holding company Incorporated in Delaware    
Aeternum Cayman Islands Ltd   A Cayman Islands company Incorporated on June 10, 2026   100% owned by Aeternum Resources Inc.
Aeternum SA (Pty) Ltd   A South African company Incorporated on May 28, 2026   100% owned by Aeternum Cayman Islands Ltd
Aeternum Resources NG Limited   A Nigerian company Incorporated on July 23, 2026   90% owned by Aeternum Cayman Islands Ltd

 

All intercompany balances and transactions have been eliminated. The 10% interest in Aeternum Resources NG Limited held by its local shareholders is presented as a non-controlling interest within equity, and the non-controlling interest’s share of Aeternum Resources NG Limited’s net loss is presented separately in the statements of operations.

 

Foreign Currency

 

The functional currency of the Company and Aeternum Cayman Islands Ltd is the U.S. dollar and that of Aeternum SA (Pty) Ltd is the South African rand. Because Nigeria is considered a highly inflationary economy, the functional currency of Aeternum Resources NG Limited is the U.S. dollar (ASC 830). Foreign-currency transactions are recorded at the exchange rate at the transaction date, and monetary items are remeasured at the closing rate, with differences recognized in the statements of operations. The financial statements of Aeternum SA (Pty) Ltd are translated into U.S. dollars at closing rates for assets and liabilities and at average rates for income and expenses, with translation differences recognized in other comprehensive income.

 

Reverse Stock Split

 

Effective October 1, 2026, the Company effected a 1-for-20 reverse stock split of its common stock. All share and per-share amounts for all periods presented have been retroactively adjusted, and an amount equal to the reduction in the par value of the common stock has been reclassified to additional paid-in capital.

 

9

 

 

Use of Estimates

 

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The Company’s accounting estimates include the collectability of receivables.

 

Exploration Stage Issuer

 

The definitions of Measured Mineral Resource, Mineral Reserve and Mineral Resource are set forth in SEC Regulation S-K, Item 1300 (“S-K 1300”).

 

Measured mineral resource is that part of a mineral resource for which quantity and grade or quality are estimated on the basis of conclusive geological evidence and sampling. The level of geological certainty associated with a measured mineral resource is sufficient to allow a qualified person to apply modifying factors in sufficient detail to support detailed mine planning and final evaluation of the economic viability of the deposit. Because a measured mineral resource has a higher level of confidence than the level of confidence of either an indicated mineral resource or an inferred mineral resource, a measured mineral resource may be converted to a proven mineral reserve or to a probable mineral reserve.

 

Mineral reserve is an estimate of tonnage and grade or quality of indicated and measured mineral resources that, in the opinion of the qualified person, can be the basis of an economically viable project. More specifically, it is the economically mineable part of a measured or indicated mineral resource, which includes diluting materials and allowances for losses that may occur when the material is mined or extracted.

 

Mineral resource is a concentration or occurrence of material of economic interest in or on the Earth’s crust in such form, grade or quality, and quantity that there are reasonable prospects for economic extraction. A mineral resource is a reasonable estimate of mineralization, taking into account relevant factors such as cut-off grade, likely mining dimensions, location or continuity, that, with the assumed and justifiable technical and economic conditions, is likely to, in whole or in part, become economically extractable. It is not merely an inventory of all mineralization drilled or sampled.

 

In accordance with S-K 1300, the Company’s mine was classified as an Exploration Stage Property as of September 30, 2026.

 

Concentration of Credit Risk

 

Financial instruments that potentially expose the Company to concentration of credit risk consist primarily of cash and accounts receivable. The Company’s cash is deposited with major financial institutions. At times, such deposits may be in excess of the Federal Deposit Insurance Corporation insurable amount (“FDIC”). As of September 30, 2026, the Company had no cash in U.S. bank accounts in excess of the FDIC’s $250,000 coverage limit. Cash of $76,380 held by the Company’s subsidiaries with banks in South Africa and Nigeria is not insured by the FDIC.

 

Cash Equivalents

 

The Company considers all highly liquid investments with a maturity of three months or less when purchased to be cash equivalents. There were no cash equivalents as of September 30, 2026 and December 31, 2025.

 

Stock-based Compensation

 

We account for equity-based transactions with employees and non-employees under the provisions of FASB ASC Topic 718, “Compensation – Stock Compensation” (“Topic 718”), which establishes that equity-based payments to employees and non-employees are recorded at the grant date the fair value of the equity instruments the entity is obligated to issue when the employees and non-employees have rendered the requisite service and satisfied any other conditions necessary to earn the right to benefit from the instruments. Topic 718 also states that observable market prices of identical or similar equity or liability instruments in active markets are the best evidence of fair value and, if available, should be used as the basis for the measurement for equity and liability instruments awarded in these share-based payment transactions. However, if observable market prices of identical or similar equity or liability instruments are not available, the fair value shall be estimated by using a valuation technique or model that complies with the measurement objective, as described in Topic 718.

 

10

 

 

Net Income (Loss) Per Common Share

 

Net income (loss) per common share is computed pursuant to section 260-10-45 of the FASB Accounting Standards Codification. Basic net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period. Diluted net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock and potentially outstanding shares of common stock during the period. The weighted average number of common shares outstanding and potentially outstanding common shares assumes that the Company incorporated as of the beginning of the first period presented. There are no potentially dilutive shares of common stock as of September 30, 2026 and 2025. Common stock subscriptions received for which shares have not been issued are excluded from the weighted average number of shares outstanding.

 

Accounts Receivable

 

Revenues that have been recognized but not yet received are recorded as accounts receivable. As of September 30, 2026 and December 31, 2025, there is $0 and $984 of accounts receivable, respectively.

 

Adoption of CECL

 

On January 1, 2023, the Company adopted Accounting Standards Update (“ASU”) 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“CECL”), using the modified retrospective method.

 

The Company maintains an allowance for credit losses (“ACL”) to cover expected lifetime losses on financial assets measured at amortized cost, including account receivables, held-to-maturity debt securities, and loan receivables. The ACL represents management’s best estimate of probable credit losses, determined using historical loss experience, current conditions, and reasonable and supportable forecasts.

 

Expected credit losses are measured on a collective (pool) basis when similar risk characteristics exist. For assets without similar risk characteristics, the Company evaluates expected losses individually. The Company applies a probability-of-default model.

 

For the periods ended September 30, 2026 and December 31, 2025, the Company determined a provision for credit losses was not needed.

 

Mining and Exploration Costs

 

The Company accounts for costs associated with mineral exploration and development in accordance with U.S. GAAP. Exploration costs, including geological and geophysical studies, exploratory drilling, sampling, testing, feasibility activities and other costs incurred to identify and evaluate mineral resources, are expensed as incurred until such time as the Company has established the existence of proven and probable reserves and determined that a mineral property is commercially viable.

 

Costs incurred to acquire mineral properties and related mineral rights are capitalized when the Company obtains the legal right to explore the property. Capitalized mineral property costs are evaluated for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable.

 

Once proven and probable reserves have been established and management has determined that development of the property is economically feasible, costs incurred to develop the property for extraction are capitalized. Capitalized development costs are depleted using the units-of-production method based upon estimated recoverable reserves once the property is placed into production.

 

The Company evaluates its mineral properties and capitalized development costs for impairment in accordance with ASC 360, Property, Plant, and Equipment. If indicators of impairment exist, recoverability is evaluated based on estimated undiscounted future cash flows. If the carrying amount is not recoverable, an impairment loss is recognized for the amount by which the carrying value exceeds fair value. Exploration and development activities are subject to significant uncertainties, including the ability to obtain necessary permits and financing, establish economically recoverable mineral reserves, and ultimately develop properties into commercially viable mining operations.

 

11

 

 

Property, Plant and Equipment and Assets under Construction

 

Property, plant and equipment is carried at cost less accumulated depreciation and impairment. Plant, equipment and infrastructure with a use independent of the mineral deposit are capitalized as assets under construction and are depreciated from the date they are available for use.

 

Vehicles are depreciated on a straight-line basis over four years.

 

Exploration, evaluation, sampling, testwork and study costs are expensed as incurred, including when they are incurred in connection with the construction of the processing plant. Project readiness, start-up and pre-production costs, and community and social investment, are expensed as incurred (ASC 720-15). During the three months ended September 30, 2026, the Company expensed $123,359 of costs that had previously been recorded in assets under construction (Note 15).

 

Segment Reporting

 

The Company accounts for segment reporting in accordance with ASC Topic 280, Segment Reporting. Operating segments are components of an entity for which discrete financial information is available and regularly reviewed by the chief operating decision maker (“CODM”) in assessing performance and allocating resources. The Company has identified its Chief Executive Officer as its CODM.

 

Following the disposition of the Company’s legacy transportation electrification business, which is presented as discontinued operations, the Company’s continuing operations are managed as one operating and reportable segment. The CODM evaluates the Company’s financial performance and makes resource allocation decisions primarily based on consolidated operating results, including operating expenses and net income (loss) from continuing operations. The Company’s CODM also reviews available cash and other measures of liquidity in assessing the resources available to fund the Company’s operations and planned business activities.

 

The accounting policies used in evaluating the Company’s segment are the same as those described in the summary of significant accounting policies.

 

The Company’s long-lived assets are located in Nigeria. The Company had no revenue from continuing operations in any period presented.

 

Recently Issued Accounting Pronouncements

 

The Company has implemented all new applicable accounting pronouncements that are in effect. These pronouncements did not have any material impact on the financial statements unless otherwise disclosed, and the Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

 

NOTE 3 – GOING CONCERN

 

The accompanying unaudited condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates the realization of assets and settlement of liabilities in the normal course of business. As of September 30, 2026, the Company had cash of $149,107, a working capital deficit of approximately $3.4 million and an accumulated deficit of approximately $4.2 million. For the nine months ended September 30, 2026, the Company incurred a loss from continuing operations of approximately $2.9 million and used approximately $1.7 million of cash in operating activities. The Company’s current liabilities include loans of $1,831,031 from related parties that have no fixed repayment terms.

 

The Company is in the early stages of developing its new business operations and has not generated revenues from continuing operations. The Company expects to incur additional costs related to its exploration, development and other planned business activities and will require additional capital to fund these activities. During the nine months ended September 30, 2026, the Company funded its operations and the construction of its Gyel processing plant primarily through advances from related parties (Paul Mann, Sidley LLC and Global Critical Minerals LLC), common stock subscriptions and sales of common stock.

 

The Company’s ability to continue as a going concern is dependent upon its ability to obtain additional financing, successfully execute its business plan and ultimately generate sufficient revenues and cash flows from operations. Management intends to seek additional funding through debt and equity financings, related-party funding and other potential sources of capital. There can be no assurance that such financing will be available when needed or on terms acceptable to the Company. These conditions raise substantial doubt about the Company’s ability to continue as a going concern for a period of one year from the date these unaudited condensed financial statements are issued.

 

The accompanying unaudited condensed consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

12

 

 

NOTE 4 – BUSINESS COMBINATION

 

2026 Business Combination

 

On February 17, 2026, Shorepower Technologies Inc. entered into an Agreement and Plan of Merger with Aeternum Health LLC. The merger became effective on June 30, 2026, with Shorepower Technologies Inc. surviving the merger and subsequently operating under the name Aeternum Health, Inc. The Company’ name change to Aeternum Resources, Inc. was filed with the Delaware Secretary of State on August 7, 2026, and was changed for trading purposes on the OTC:Pink market following FINRA completing its review of this corporate action on October 2, 2026.

 

Management determined that both Aeternum Health LLC and Shorepower Technologies Inc. met the definition of a business under ASC 805, Business Combinations, as of the acquisition date. Accordingly, the reverse acquisition was accounted for as a business combination using the acquisition method of accounting in accordance with ASC 805-40, Reverse Acquisitions.

 

The consolidated financial statements reflect the historical carrying amounts of the assets and liabilities of Aeternum Health LLC, the accounting acquirer, while the identifiable assets acquired and liabilities assumed of Shorepower Technologies Inc., the accounting acquiree, were recognized and measured in accordance with ASC 805, generally at their estimated fair values as of the acquisition date.

 

Concurrently with the closing of the merger on June 30, 2026, the Company disposed of its legacy transportation electrification business. The disposition represented a strategic shift in the Company’s operations and has been presented as discontinued operations in accordance with ASC 205-20. Refer to NOTE 8 – DISCONTINUED OPERATIONS.

 

NOTE 5 – DEPOSITS AND PREPAIDS

 

As of September 30, 2026 and December 31, 2025, the Company had deposits, prepaids and other current assets of $1,354 and $0, respectively. The deposits and prepaids of $1,226,313 held at June 30, 2026 were mainly advance payments for equipment, engineering and other services for the Company’s mining and mineral processing project in Nigeria; $1,159,882 of these advances was applied to equipment and services received during the three months ended September 30, 2026 and is included in property, plant and equipment (Note 15).

 

NOTE 6 – INVENTORY

 

Inventories were stated at the lower of cost or market. Cost was principally determined using the last-in, first-out (LIFO) method. The Company periodically assesses if any of the inventory has become obsolete or if the value has fallen below cost. When this occurs, the Company recognizes an expense for inventory write down. Total inventory at September 30, 2026 and December 31, 2025 were $0 and $37,199, respectively. The inventory was transferred with the discontinued business (Note 8).

 

NOTE 7 – LOAN PAYABLE

 

As of September 30, 2026 and December 31, 2025, the Company has a loan payable to a third party of $0 and $111,395, respectively. The loan is non-interest bearing and due on demand.

 

NOTE 8 – DISCONTINUED OPERATIONS

 

In connection with the merger with Aeternum Health LLC and the Company’s strategic shift from transportation electrification infrastructure to the exploration and development of critical minerals, the Company determined to divest its legacy Shorepower transportation electrification business. The disposition represented a strategic shift in the Company’s operations and, accordingly, the results of the legacy Shorepower business have been classified as discontinued operations for all periods presented.

 

13

 

 

The Company recognized a gain on the disposal of the discontinued business of $2,037,315, all in the six months ended June 30, 2026. The loss from the operations of the discontinued business was $153,553 for the nine months ended September 30, 2026 (all before the disposal on June 30, 2026) and $137,860 and $237,824 for the three and nine months ended September 30, 2025, respectively. The operating results of the discontinued business have been excluded from continuing operations and presented separately as discontinued operations in the accompanying condensed consolidated statements of operations.

 

   For the nine months ended September 30, 2026 
Liabilities transferred/derecognized  $2,481,068 
Less: assets transferred   (443,753)
Gain on disposition  $2,037,315 

 

In connection with the disposition, certain obligations associated with the discontinued business remained outstanding. Such obligations included promissory notes payable to Jeff Kim, the Company’s former executive officer, with aggregate principal outstanding of $1,045,453 prior to the disposition. Accrued interest related to these promissory notes totaled $249,732. In addition, Mr. Kim had previously paid certain operating expenses on behalf of the Company. Amounts payable to Mr. Kim related to such operating expenses were $54,119 at the date of the disposal and $48,864 as of December 31, 2025. These obligations were transferred and derecognized as part of discontinuation of the Shorepower business.

 

For the nine months ended September 30, 2026, net cash used in operating activities attributable to the discontinued business was approximately $115,498.

 

NOTE 9 – RELATED PARTY TRANSACTIONS

 

On February 17, 2026, the Company sold 25,000 shares of common stock to Mr. Kim for total cash proceeds of $7,500 to pay expenses.

 

On March 16, 2026, the Company sold 5,000 shares of common stock to Mr. Kim for total cash proceeds of $5,000 to pay expenses.

 

On May 2, 2026, the Company sold 5,000 shares of common stock to Mr. Kim for total cash proceeds of $6,000 to pay expenses.

 

Since inception of Aeternum Health LLC, Paul Mann, the Company’s President and Executive Chairman, has funded the Company through advances and the direct payment of Company expenses. During the nine months ended September 30, 2026, Mr. Mann advanced $4,070,000 to the Company ($2,170,000 in the six months ended June 30, 2026 and $1,900,000 in the three months ended September 30, 2026). On August 26, 2026, $1,500,000 of the notes payable to Mr. Mann was exchanged for 3,750,000 shares of common stock (Note 12). As of September 30, 2026, notes payable to Mr. Mann were $2,580,348 (Note 10).

 

On October 28, 2025, the Company entered into a consulting agreement with Paul Mann, sole member, pursuant to which Mr. Mann agreed to provide corporate development, business strategy, and fundraising services to the Company. The agreement has a term through December 31, 2027, unless terminated earlier in accordance with its terms. As compensation, the Company is obligated to pay Mr. Mann consulting fees of $10,000 per month and reimburse certain approved business expenses. As of September 30, 2026, accrued consulting fees payable to Mr. Mann were $90,000.

 

On July 22, 2026, the Company issued 2,450,000 shares of common stock to Mr. Mann pursuant to the merger agreement. On August 26, 2026, the Company issued 2,000,000 shares of common stock to Mr. Mann, which vested immediately on the signing of his employment agreement, and recognized stock-based compensation of $800,000 ($0.40 per share).

 

Sidley LLC, an entity related to Mr. Mann, paid supplier invoices of $1,253,509 directly on behalf of the Company. On July 1, 2026, the Company paid $400,000 to Rowley 1898 Labs LLC, which has been applied as a repayment of the amount due to Sidley LLC. As of September 30, 2026, the loan payable to Sidley LLC was $853,509. The loan is unsecured, non-interest bearing and has no fixed repayment terms, and is classified as current.

 

14

 

 

On September 7 and 16, 2026, Global Critical Minerals LLC (“GCM”), an associated company of Mr. Mann, paid R15,884,731 ($977,522) to Aeternum SA (Pty) Ltd on behalf of Sidley LLC, in settlement of invoices issued by Aeternum SA (Pty) Ltd to Sidley LLC. The Company has presented the amount received as a loan payable to GCM rather than as revenue. The loan is unsecured, non-interest bearing and has no fixed repayment terms, and is classified as current. As of September 30, 2026, the loan payable to GCM was $977,522.

 

On July 28, 2026, Mr. Kim cancelled and returned 331,500 shares of common stock to the Company.

 

On August 26, 2026, the Company issued 2,500,000 shares of common stock to Manaslu LLC under the option arrangement described in Note 11, which is being cancelled; as of September 30, 2026, Manaslu LLC held approximately 19.1% of the outstanding shares.

 

NOTE 10 – NOTE PAYABLE - RELATED PARTY

 

The following summarizes the notes payable to Mr. Mann as of September 30, 2026.

 

All notes bear no interest unless an event of default occurs, at which time interest accrues at 1.5% per month or the maximum rate permitted by law. The notes mature two years after issuance and may be prepaid at any time without penalty. Upon the occurrence of an event of default, the outstanding principal and any accrued interest become immediately due and payable.

 

   As of September 30, 2026 
Balance, December 31, 2025  $10,348 
Advances, January to June 2026  $2,170,000 
Advances, July to September 2026  $1,900,000 
Exchanged for common stock, August 26, 2026  $(1,500,000)
Total  $2,580,348 

 

NOTE 11 – COMMITMENT AND CONTINGENCIES

 

On August 7, 2026, the Company agreed to acquire the option held by Manaslu LLC to purchase a 50.1% interest in ARM for 2,500,000 shares of common stock and 2,000,000 shares of Series B preferred stock. The 2,500,000 shares of common stock were issued on August 26, 2026. The option was not transferred to the Company and is being cancelled, and the Series B preferred shares had not been issued as of the date of these financial statements. The 2,500,000 shares of common stock are recorded at par value against additional paid-in capital, with no value attributed to the option.

 

On September 21, 2026, the Company signed a Membership Interest Purchase Agreement (“MIPA”) with American Renaissance Resources LLC (“ARR”) to acquire 100% of the membership interests in American Renaissance Minerals LLC (“ARM”), a Delaware limited liability company, and through ARM its interest in its Cameroonian subsidiary (“ARM Cameroon”) and the Nkamouna Nickel-Cobalt project in Cameroon. As of September 30, 2026, and as of the date of these financial statements, the transaction had not closed. Nothing has been recorded for ARM, and neither the 750,000 shares of common stock issuable at closing nor the contingent consideration of up to 5,916,666 shares of common stock has been issued.

 

Closing depends on conditions that include:

 

●completion of the ARM financial statements the Company must file with the SEC, expected by November 30, 2026;
●ARM’s total liabilities at closing not exceeding $1,000,000;
●an amendment to ARM’s $1,000,000 Gardiner Investments LLC note, deferring repayment to the earlier of the Initial Investment Decision Date and a Project Disposal;
●delivery of the closing documents, including a consulting agreement and an investor rights agreement with ARR, and a release from Andrew Horn.

 

Either party may terminate the MIPA if closing has not occurred by January 31, 2027. No broker’s or finder’s fee is payable on the transaction, including to INTE Securities under the December 29, 2025 investment agreement with ARM.

 

15

 

  

NOTE 12 – COMMON STOCK

 

On February 17, 2026, the Company issued 50,000 shares of common stock to OpConnect Inc for the purchase of new software that is OCPP compliant which is the industry standard for interchangeability to more efficiently monitor and control the EV and truck stations that allows customers to purchase power through the web or with a smartphone app and that has the necessary features needed for today’s customers to conveniently purchase power/electricity in place of the Company’s outdated software that is also expensive and time consuming for the Company to monitor. The shares were valued at $0.30, for total value of $15,000. The $15,000 has been capitalized to intangible assets on the balance sheet. The software was transferred with the discontinued business (Note 8).

 

On February 17, 2026, the Company sold 25,000 shares of common stock to EROP Enterprises, LLC for total cash proceeds of $7,500 to pay expenses.

 

On February 17, 2026, the Company granted 5,000 shares of common for services. The shares were valued at $0.30, the closing stock price on the date of grant, for a total non-cash expense of $1,500.

 

On March 16, 2026, the Company sold 20,000 shares of common stock to EROP Enterprises, LLC for total cash proceeds of $20,000 to pay expenses.

 

On March 16, 2026, the Company sold 20,000 shares of common stock to a third party for total cash proceeds of $20,000 to pay expenses.

 

On April 24, 2026, the Company sold 25,000 shares of common stock to a third party for total cash proceeds of $30,000 to pay expenses.

 

On May 14, 2026, the Company granted 1,250 shares of common for services. The shares were valued at $2.10, the closing stock price on the date of grant, for a total non-cash expense of $2,625.

 

On July 22, 2026, the Company issued 2,450,000 shares of common stock to Paul Mann pursuant to the February 17, 2026 merger agreement. The shares were recorded at par value against additional paid-in capital.

 

On July 28, 2026, the Company issued 96,000 shares of common stock to Orion 4 LLC as finder’s fees in connection with the merger agreement. On the same date, Mr. Kim, the Company’s former Chief Executive Officer, cancelled and returned 331,500 shares of common stock.

 

On August 26, 2026, the Company issued 2,500,000 shares of common stock to Manaslu LLC under the option arrangement described in Note 11, which is being cancelled, 3,750,000 shares of common stock to Mr. Mann in exchange for $1,500,000 of notes payable ($0.40 per share), and 2,000,000 shares of common stock to Mr. Mann as stock-based compensation of $800,000 ($0.40 per share) (Note 9). The shares issued to Orion 4 LLC were recorded at par value, and the shares issued to Manaslu LLC were recorded at par value with no value attributed to the option (Note 11).

 

In September 2026, the Company received $1,775,000 of subscriptions for common stock from Orion – AETN A Series of V360 ($775,000), PCS Management LLC ($500,000) and Paul Sohn ($500,000). As of November 2, 2026, no shares had been issued for these subscriptions, and the amount is presented as common stock subscriptions received – shares to be issued.

 

Effective October 1, 2026, the Company effected a 1-for-20 reverse stock split, which has been applied retroactively to all periods presented. The reduction in the par value of the common stock, $2,508,999 at September 30, 2026, has been reclassified to additional paid-in capital. Effective August 19, 2026, the Company increased its authorized common stock to 500,000,000 shares.

 

As of September 30, 2026 and December 31, 2025, there were 13,105,260 and 2,459,510 shares of common stock issued, respectively.

 

Refer to Note 9 for common stock issued to a related party.

 

16

 

 

NOTE 13 – PREFERRED STOCK

 

There are 1,105,644 shares designated as Series A preferred stock (“Series A”). Each share of the Series A has five votes, is entitled to a 2% cumulative annual dividend, and is convertible at any time into shares of common stock.

 

As of September 30, 2026, there were no shares of Series A issued and outstanding.

 

As part of the merger, the Company designated 2,000,000 of its 10,000,000 shares of authorized preferred stock as Series B preferred. Each Series B preferred share has voting power of 40 shares of the Company’s common stock. The Series B preferred will have no conversion feature.

 

As of September 30, 2026 and December 31, 2025, there are 2,000,000 shares of Series B preferred issued and outstanding.

 

NOTE 14 – INCOME TAXES

 

The Company accounts for income taxes in accordance with ASC Topic 740, Income Taxes. Deferred tax assets and liabilities are recognized for temporary differences between the financial statement carrying amounts and the tax bases of assets and liabilities using enacted tax rates expected to apply in the years in which those temporary differences are expected to be recovered or settled.

 

As of September 30, 2026, the Company had a net operating loss carryforward for federal income tax purposes of approximately $758,000. The federal net operating loss carryforwards generated after 2017 may be carried forward indefinitely, subject to certain limitations under Section 382 of the Internal Revenue Code. The Company’s subsidiaries in South Africa and Nigeria incurred tax losses for the nine months ended September 30, 2026, and the Cayman Islands does not levy income tax.

 

The Company recorded a full valuation allowance against its deferred tax assets as management determined that it is more likely than not that the deferred tax assets will not be realized. The valuation allowance increased primarily due to current period operating losses.

 

For the three and nine months ended September 30, 2026 and 2025, the Company recorded no income tax expense or benefit due to the full valuation allowance recorded against deferred tax assets.

 

The effective tax rate differed from the statutory federal income tax rate for the nine months ended September 30, 2026 and 2025 primarily due to changes in the valuation allowance.

 

A reconciliation of the statutory federal income tax rate to the Company’s effective tax rate is as follows:

 

   September 30, 2026   September 30, 2025 
Federal statutory tax rate   (21.0)%   (21.0)%
State taxes, net of federal benefit   (0.0)%   (0.0)%
Change in valuation allowance   21.0%   21.0%
Effective income tax rate   0.0%   0.0%

 

17

 

 

NOTE 15 – PROPERTY, PLANT AND EQUIPMENT AND MINERAL RIGHTS

 

The Company’s property, plant and equipment, mineral rights and land relate to the Gyel tin, niobium and tantalum project in Nigeria, which is held by Aeternum Resources NG Limited. The Company had no property, plant and equipment or mineral rights as of December 31, 2025. As of September 30, 2026, they comprised:

 

   September 30, 2026 
Mineral rights and mining licences  $1,840,000 
Land and surface rights   152,557 
Total mineral rights and land  $1,992,557 
      
Vehicles  $81,004 
      
Assets under construction:     
Earthworks and civils  $804,103 
Process plant and equipment   1,171,807 
Mining, dredging and pumping equipment   1,386,554 
Power, electrical and instrumentation   615,967 
Site infrastructure and services   49,602 
Buildings and furniture   284,393 
Engineering, project management and studies   625,591 
Transport, freight and import duties   29,919 
Total assets under construction  $4,967,936 

 

Mineral rights comprise mining licences acquired for $1,840,000. Assets under construction comprise the Gyel Phase 1 processing plant, dredging and pumping equipment, power and other infrastructure, and the related engineering, freight and import duties; they are not depreciated until they are available for use. During the three months ended September 30, 2026, the Company reassessed the costs recorded in assets under construction and expensed $123,359 of exploration, evaluation and other costs that do not qualify for capitalization: $84,724 is included in exploration expenditures, $18,369 in professional fees, $13,284 in insurance, $5,077 in project start-up and pre-production costs and $1,905 in travel and events.

 

NOTE 16 – SUBSEQUENT EVENTS

 

In accordance with ASC 855, Subsequent Events, the Company evaluated subsequent events and transactions occurring after September 30, 2026 through the date these unaudited financial statements were available to be issued. The Company identified certain subsequent events requiring disclosure, as described below.

 

Effective October 1, 2026, the Company effected a 1-for-20 reverse stock split of its common stock, which has been applied retroactively in these financial statements (Note 12).

 

On October 6, 2026, StoneX Financial Inc. paid $250,000 to the Company as a subscription for common stock. As of November 2, 2026, the shares had not been issued.

 

Subsequent to September 30, 2026, the Company entered into Simple Agreements for Future Equity (“SAFEs”) with eight investors for aggregate purchase amounts of $1,910,000. Each SAFE gives the investor the right to receive shares of the Company’s capital stock in the future. The SAFEs carry a post-money common stock share price cap of $1.60 (post reverse stock split) per share. They bear no interest and have no maturity date.

 

If the Company completes an equity financing before a SAFE terminates, the SAFE converts automatically into shares of common stock. The number of shares is the greater of (1) the purchase amount divided by the lowest price per share paid in the financing, or (2) the purchase amount divided by the price implied by the valuation cap. If a liquidity event (such as a change of control or IPO) occurs first, the holder receives the greater of its purchase amount or the amount payable on its as-converted shares. If a dissolution event occurs first, the holder receives its purchase amount before any distribution to common stockholders.

 

As of the date these financial statements were available to be issued, the Company had not received any of the purchase amounts under the SAFEs. The Company will record the SAFEs when it receives the funds.

 

As of the date of these financial statements, the acquisition of ARM under the Membership Interest Purchase Agreement signed in September 2026 had not closed (Note 11).

 

18

 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION.

 

Forward-looking Statements

 

Unless the context indicates otherwise, as used in this Quarterly Report, the terms “AETN,” “Aeternum,” “we,” “us,” “our,” “our company” and “our business” refer to Aeternum Resources, Inc. and its subsidiaries. Certain statements, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are “forward-looking statements.” These forward-looking statements generally are identified by the words “believes,” “project,” “expects,” “anticipates,” “estimates,” “intends,” “strategy,” “plan,” “may,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. Forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties which may cause actual results to differ materially from the forward-looking statements. Our ability to predict results or the actual effect of future plans or strategies is inherently uncertain. Factors which could have a material adverse effect on our operations and future prospects include but are not limited to: changes in economic conditions, legislative/regulatory changes, availability of capital, interest rates, competition, and generally accepted accounting principles. These risks and uncertainties should also be considered in evaluating forward-looking statements and undue reliance should not be placed on such statements.

 

OVERVIEW

 

Until March 22, 2023, we were an emerging diversified investment vehicle focused on acquiring equity in companies that we believed were or could be leaders in the markets in which they were involved.

 

On November 23, 2022, we entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Shurepower, LLC d/b/a Shorepower Technologies (“Shorepower”), under which Shorepower was merged with and into SPEV (formerly “USBL”) The closing occurred on March 22, 2023.

 

Shorepower is a transportation electrification infrastructure manufacturer and service provider of Electric Vehicle Supply Equipment (EVSE), Truck Stop Electrification (TSE) and electric standby Transport Refrigeration Unit (eTRU) stations. They have 60 operational TSE facilities with over 1,800 individual electrified parking spaces in 31 states. Shorepower’s stations are EPA SmartWay-Verified and CARB-Verified. Shorepower has its headquarters in Hillsboro, Oregon, near Portland, Oregon, and an office in the Detroit, Michigan metro area.

 

On February 17, 2026, Shorepower entered into a merger agreement with Aeternum Health LLC, pursuant to which Aeternum Health merged into Shorepower, with Shorepower as the surviving entity. Upon closing, Shorepower’s CEO and sole director, Jeff Kim, resigned. The Company has divested its existing transportation electrification business and shifted its focus to both (i) mining of critical minerals required by the U.S. Government that are potentially not easily obtained because of being located in countries from which such minerals could a challenge for political and competitive reasons as well as (ii) potentially developing services, products and solutions to increase longevity and achieve optimal health.

 

As consideration for the merger, the Company is obligated to issue shares to Paul Mann. Aeternum Health will contribute a minimum, $1,500,000 in the form of (a) securing sources of critical minerals and/or contributing know-how and data from a single patient relating to a novel peptide mix in development for longevity and anti-aging and any IP resulting from or developed from the know-how and data collected; and (b) a minimum of $300,000 in cash. In connection with the transaction, Jeff Kim has agreed to cancel up to 650,000 shares of common stock in stages.

 

In March 2026, the Company changed its name to Aeternum Health, Inc. and its trading symbol to AETN. Effective April 3, 2026, the Company increased its authorized shares of common stock from 100 million to 250 million. The merger closed on June 30, 2026.

 

During the three months ended September 30, 2026, the Company formed Aeternum Resources NG Limited in Nigeria, which is 90% owned, and continued construction of the Phase 1 processing plant at the Gyel tin, niobium and tantalum project on the Jos Plateau. The Company has not established mineral reserves. The Company’ name change to Aeternum Resources, Inc. was filed with the Delaware Secretary of State on August 7, 2026, and was changed for trading purposes on the OTC:Pink market following FINRA completing its review of this corporate action on October 2, 2026. Effective August 19, 2026, the Company increased its authorized shares of common stock to 500 million. Effective October 1, 2026, the Company effected a 1-for-20 reverse stock split; all share and per-share amounts in this report are adjusted for the reverse split.

 

Results of Operations

 

In connection with the Company’s merger with Aeternum Health LLC and its strategic shift away from its legacy transportation electrification business, the Company disposed of its Shorepower operations during the three months ended June 30, 2026. As a result, the historical operating results of the Shorepower business have been classified as discontinued operations for all periods presented. Accordingly, the discussion of the Company’s results of operations below primarily reflects the results of the Company’s continuing operations.

 

For the nine months ended September 30, 2026, the Company recognized a loss from the operations of the discontinued business of $153,553 and a gain of $2,037,315 on its disposal, both in the six months ended June 30, 2026. For the three and nine months ended September 30, 2025, losses from the operations of the discontinued business were $137,860 and $237,824, respectively.

 

As a result of the disposition, the operating results of the Shorepower business will not be included in the Company’s continuing operations in future periods. Consequently, the Company’s historical results may not be indicative of its future operating results as it continues to develop and execute its new business strategy.

 

19

 

 

Three Months Ended September 30, 2026 Compared to Three Months Ended September 30, 2025

 

The Company generated no revenue from continuing operations during the three months ended September 30, 2026 or 2025. The $977,522 received in September 2026 by Aeternum SA (Pty) Ltd from Global Critical Minerals LLC, an associated company of Paul Mann, is presented as a related-party loan rather than as revenue (Note 9).

 

During the three months ended September 30, 2026, the Company incurred operating expenses of $2,607,783, compared to no operating expenses from continuing operations during the comparable period in 2025. Operating expenses consisted of share-based compensation – related party of $800,000, exploration expenditures of $431,582, project start-up and pre-production costs of $402,678, professional fees of $238,188, travel and events of $232,784, staff and contractor costs of $222,577, insurance of $168,044, community and social investment of $36,630, IT and systems costs of $26,637, other administrative expenses of $25,834 and investor relations and listing costs of $22,829. The increase reflects the start of exploration and project development activities at the Gyel project, including $123,359 of costs previously recorded in assets under construction that were expensed in the quarter, and the stock award to Mr. Mann. After a foreign exchange loss of $15,414, the Company reported a loss from continuing operations of $2,623,197 for the three months ended September 30, 2026, of which $120,802 was attributable to the non-controlling interest, compared to no income or loss from continuing operations for the three months ended September 30, 2025.

 

Nine Months Ended September 30, 2026 Compared to Nine Months Ended September 30, 2025

 

The Company generated no revenue from continuing operations during the nine months ended September 30, 2026 or 2025.

 

Operating expenses were $2,908,662 for the nine months ended September 30, 2026, compared to no operating expenses from continuing operations during the nine months ended September 30, 2025. Operating expenses during the 2026 period consisted of share-based compensation – related party of $800,000, exploration expenditures of $521,804, project start-up and pre-production costs of $405,874, professional fees of $393,578 (including related-party consulting fees of $60,000), staff and contractor costs of $267,456, travel and events of $232,784, insurance of $168,044, community and social investment of $36,630, IT and systems costs of $32,451, other administrative expenses of $26,619 and investor relations and listing costs of $23,422. These expenses reflect costs associated with the Company’s new business activities, including mineral exploration and development activities, project management, professional services and consulting. The Company reported a loss from continuing operations of $2,924,076 for the nine months ended September 30, 2026, compared to no income or loss from continuing operations for the nine months ended September 30, 2025. Including income from discontinued operations of $1,883,762, the net loss for the nine months ended September 30, 2026 was $1,040,314, of which $919,512 was attributable to the Company’s stockholders.

 

Liquidity and Capital Resources

 

As of September 30, 2026, the Company had cash of $149,107 and a working capital deficit of approximately $3.4 million. The Company had no revenue from continuing operations during the nine months ended September 30, 2026 and used approximately $1.7 million of cash in operating activities during the period.

 

During the nine months ended September 30, 2026, the Company financed its operations and the construction of the Gyel processing plant primarily through related-party borrowings, common stock subscriptions and issuances of common stock. The Company received $4.07 million in loans from Paul Mann and $977,522 from Global Critical Minerals LLC, repaid $400,000 of related-party loans, received $1,775,000 of common stock subscriptions, and received $77,500 from sales of common stock to third parties and $18,500 from sales of common stock to related parties. Net cash provided by financing activities was approximately $6.5 million, and net cash used in investing activities, mainly for the Gyel processing plant and equipment, was approximately $4.7 million. In addition, related parties paid $1.07 million of property, plant and equipment and $0.18 million of expenses directly on the Company’s behalf. On October 6, 2026, the Company received a further $250,000 common stock subscription.

 

The Company is in the early stages of developing its continuing business operations and expects to incur additional expenditures related to exploration, project development, professional services, consulting and other planned business activities. The Company has not generated revenues from continuing operations and expects that additional financing will be required to fund its planned activities.

 

20

 

 

Management intends to fund the Company’s operations through a combination of available cash, additional debt and equity financings, related-party funding and other potential sources of capital. There can be no assurance that additional financing will be available when required or on terms acceptable to the Company. The Company’s ability to continue its planned operations is dependent upon obtaining sufficient financing, successfully executing its business plan and ultimately generating sufficient revenues and cash flows from operations. These conditions raise substantial doubt about the Company’s ability to continue as a going concern for a period of one year from the date the financial statements are issued.

 

In addition, the Company has entered into arrangements that may require significant future capital. On September 21, 2026, the Company signed a Membership Interest Purchase Agreement to acquire 100% of the membership interests in American Renaissance Minerals LLC, which holds the Nkamouna Nickel-Cobalt project in Cameroon. The transaction had not closed as of the date of this report. Completing the Gyel Phase 1 processing plant and, if it closes, the ARM acquisition are expected to require additional capital beyond the Company’s current resources.

 

Off Balance Sheet Arrangements

 

We have no off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors.

 

Critical Accounting Policies

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Note 2 to the Financial Statements describes the significant accounting policies and methods used in the preparation of the Financial Statements. Estimates are used for, but not limited to, contingencies and taxes. Actual results could differ materially from those estimates. The following critical accounting policies are impacted significantly by judgments, assumptions, and estimates used in the preparation of the Financial Statements.

 

The Company considers the following policies to be critical: (i) the classification of project costs between exploration expenditures, which are expensed, and property, plant and equipment and assets under construction, which are capitalized (Notes 2 and 15); (ii) the classification of amounts received from related parties, including the amounts received from Global Critical Minerals LLC, which are presented as a loan payable (Note 9); and (iii) the going concern assessment (Note 3).

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

 

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and, as such, are not required to provide the information under this Item.

 

ITEM 4. CONTROLS AND PROCEDURES

 

Disclosure Controls and Procedures

 

Each of our principal executive and principal financial officer has evaluated the effectiveness of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as of the end of the period covered by this quarterly report. Based on their evaluation, each such person concluded that our disclosure controls and procedures were not effective as of September 30, 2026.

 

In designing and evaluating disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable, not absolute assurance of achieving the desired objectives. Also, the design of a control system must reflect the fact that there are resource constraints and the benefits of controls must be considered relative to their costs.

 

Changes in Internal Control over Financial Reporting.

 

Our management has evaluated whether any change in our internal control over financial reporting occurred during the last fiscal quarter. During the quarter ended September 30, 2026, following the merger with Aeternum Health LLC and the disposal of the Shorepower business, our internal control over financial reporting changed: new management assumed responsibility for financial reporting, and we began operating accounting processes for our subsidiaries in the Cayman Islands, South Africa and Nigeria. Management is continuing to design and implement internal controls over financial reporting for the combined business. Other than these changes, there has been no change in our internal control over financial reporting during the quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

21

 

 

PART II - OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

None

 

ITEM 1A. RISK FACTORS

 

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and, as such, are not required to provide the information under this Item.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

On July 22, 2026, the Company issued 2,450,000 shares of common stock to Paul Mann pursuant to the February 17, 2026 merger agreement.

 

On July 28, 2026, the Company issued 96,000 shares of common stock to Orion 4 LLC as finder’s fees.

 

On August 26, 2026, the Company issued 2,500,000 shares of common stock to Manaslu LLC under the option arrangement described in Note 11, 3,750,000 shares of common stock to Paul Mann in exchange for $1,500,000 of notes payable and 2,000,000 shares of common stock to Paul Mann under his employment agreement.

 

In September 2026, the Company received $1,775,000 of subscriptions for common stock from three investors; the shares had not been issued as of the date of this report.

 

The securities were issued in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

None

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not applicable

 

ITEM 5. OTHER INFORMATION

 

None

 

ITEM 6. EXHIBITS

 

Exhibit

No.

  Description
     
31.1   Certification of the Chief Executive pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2   Certification of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1   Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS   Inline XBRL Instance Document
101.SCH   Inline XBRL Taxonomy Extension Schema Document
101.CAL   Inline XBRL Taxonomy Calculation Linkbase Document
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB   Inline XBRL Taxonomy Label Linkbase Document
101.PRE   Inline XBRL Taxonomy Presentation Linkbase Document
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in exhibit 101).

 

22

 

 

SIGNATURES

 

In accordance with Section 13 or 15(d) of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

AETERNUM RESOURCES, INC.  
   
Dated: November 16, 2026 /s/ Josua Oosthuizen
  Josua Oosthuizen
 

Chief Executive Officer

(Principal Executive Officer)

   
Dated: November 16, 2026 /s/ Pieter Scholtz
  Pieter Scholtz
 

Chief Financial Officer

(Principal Financial Officer and Principal Accounting Officer)

 

23

 

Keep reading